57 research outputs found
Lola Badia i Albert Soler (eds.), 'Intel·lectuals i escriptors a la Baixa Edat Mitjana' /
Volum commemoratiu dels set anys d'activitat del Seminari de Literatura Medieval de la Universitat de Barcelona (1988-1994)PresentaciĂł dels nous treballs del volum
The Classical Tradition in Medieval Catalan, 1300-1500 : Translation, Imitation, and Literacy. A cura di LluĂs CabrĂ©, Alejandro Coroleu, Montserrat Ferrer, Albert Lloret e Josep Pujol. Woodbridge: Tamesis, Serie A: MonografĂas, 374, 2018, 289 p
Obra ressenyada: LluĂs CABRĂ; Alejandro COROLEU; Montserrat FERRER; Albert LLORET; Josep PUJOL (eds.), The Classical Tradition in Medieval Catalan, 1300-1500.Translation, Imitation, and Literacy. Woodbridge: Tamesis, 2018
Ressenyes
Ăndex de l'obra ressenya: LluĂs CABRĂ, Alejandro COROLEU i Jill KRAYE (eds.), Fourteenth-Century Classicism : Petrarch and Bernat Metge. TorĂ: The Warburg Institute - Nino Aragno Editore, 2012
CINGOLANI, Stefano M.: El somni d'una cultura: «Lo somni» de Bernat Metge, Barcelona, Quaderns Crema, 2002 («Assaig», nĂșm. 33)
Obra ressenyada: Stefano M. CINGOLANI, El somni d'una cultura: «Lo somni» de Bernat Metge. Barcelona: Quaderns Crema, 2002
Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study
Background: We aimed to describe the epidemiology, risk factors, and clinical outcomes of co-infections and superinfections in onco-hematological patients with COVID-19. Methods: International, multicentre cohort study of cancer patients with COVID-19. All patients were included in the analysis of co-infections at diagnosis, while only patients admitted at least 48 h were included in the analysis of superinfections. Results: 684 patients were included (384 with solid tumors and 300 with hematological malignancies). Co-infections and superinfections were documented in 7.8% (54/684) and 19.1% (113/590) of patients, respectively. Lower respiratory tract infections were the most frequent infectious complications, most often caused by Streptococcus pneumoniae and Pseudomonas aeruginosa. Only seven patients developed opportunistic infections. Compared to patients without infectious complications, those with infections had worse outcomes, with high rates of acute respiratory distress syndrome, intensive care unit (ICU) admission, and case-fatality rates. Neutropenia, ICU admission and high levels of C-reactive protein (CRP) were independent risk factors for infections. Conclusions: Infectious complications in cancer patients with COVID-19 were lower than expected, affecting mainly neutropenic patients with high levels of CRP and/or ICU admission. The rate of opportunistic infections was unexpectedly low. The use of empiric antimicrobials in cancer patients with COVID-19 needs to be optimized
Poly[ADP-Ribose] Polymerase-1 Expression Is Related To Cold Ischemia, Acute Tubular Necrosis, and Delayed Renal Function In Kidney Transplantation
Cold ischemia time especially impacts on outcomes of expanded-criteria donor (ECD) transplantation. Ischemia-reperfusion (IR) injury produces excessive poly[ADP-Ribose] Polymerase-1 (PARP-1) activation. The present study explored the hypothesis that increased tubular expression of PARP-1 contributes to delayed renal function in suboptimal ECD kidney allografts and in non-ECD allografts that develop posttransplant acute tubular necrosis (ATN)
Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases
Objective
Clinical heterogeneity, a hallmark of systemic autoimmune diseases, impedes early diagnosis and effective treatment, issues that may be addressed if patients could be classified into groups defined by molecular pattern. This study was undertaken to identify molecular clusters for reclassifying systemic autoimmune diseases independently of clinical diagnosis.
Methods
Unsupervised clustering of integrated whole blood transcriptome and methylome cross-sectional data on 955 patients with 7 systemic autoimmune diseases and 267 healthy controls was undertaken. In addition, an inception cohort was prospectively followed up for 6 or 14 months to validate the results and analyze whether or not cluster assignment changed over time.
Results
Four clusters were identified and validated. Three were pathologic, representing âinflammatory,â âlymphoid,â and âinterferonâ patterns. Each included all diagnoses and was defined by genetic, clinical, serologic, and cellular features. A fourth cluster with no specific molecular pattern was associated with low disease activity and included healthy controls. A longitudinal and independent inception cohort showed a relapseâremission pattern, where patients remained in their pathologic cluster, moving only to the healthy one, thus showing that the molecular clusters remained stable over time and that single pathogenic molecular signatures characterized each individual patient.
Conclusion
Patients with systemic autoimmune diseases can be jointly stratified into 3 stable disease clusters with specific molecular patterns differentiating different molecular disease mechanisms. These results have important implications for future clinical trials and the study of nonresponse to therapy, marking a paradigm shift in our view of systemic autoimmune diseases
CD40: Novel Association with Crohn's Disease and Replication in Multiple Sclerosis Susceptibility
Background: A functional polymorphism located at 21 from the start codon of the CD40 gene, rs1883832, was previously
reported to disrupt a Kozak sequence essential for translation. It has been consistently associated with Gravesâ disease risk in
populations of different ethnicity and genetic proxies of this variant evaluated in genome-wide association studies have
shown evidence of an effect in rheumatoid arthritis and multiple sclerosis (MS) susceptibility. However, the protective allele
associated with Gravesâ disease or rheumatoid arthritis has shown a risk role in MS, an effect that we aimed to replicate in
the present work. We hypothesized that this functional polymorphism might also show an association with other complex
autoimmune condition such as inflammatory bowel disease, given the CD40 overexpression previously observed in Crohnâs
disease (CD) lesions.
Methodology: Genotyping of rs1883832C.T was performed in 1564 MS, 1102 CD and 969 ulcerative colitis (UC) Spanish
patients and in 2948 ethnically matched controls by TaqMan chemistry.
Principal Findings: The observed effect of the minor allele rs1883832T was replicated in our independent Spanish MS
cohort [p= 0.025; OR (95% CI)= 1.12 (1.01â1.23)]. The frequency of the minor allele was also significantly higher in CD
patients than in controls [p= 0.002; OR (95% CI)= 1.19 (1.06â1.33)]. This increased predisposition was not detected in UC
patients [p= 0.5; OR (95% CI)= 1.04 (0.93â1.17)].
Conclusion: The impact of CD40 rs1883832 on MS and CD risk points to a common signaling shared by these autoimmune
conditions.Peer reviewe
Epigenetic loss of RNAâmethyltransferase NSUN5 in glioma targets ribosomes to drive stress adaptive translational program
Tumors have aberrant proteomes that often do not match their corresponding transcriptome profiles. One possible cause of this discrepancy is the existence of aberrant RNA modification landscapes in the so-called epitranscriptome. Here, we report that human glioma cells undergo DNA methylation-associated epigenetic silencing of NSUN5, a candidate RNA methyltransferase for 5-methylcytosine. In this setting, NSUN5 exhibits tumor-suppressor characteristics in vivo glioma models. We also found that NSUN5 loss generates an unmethylated status at the C3782 position of 28S rRNA that drives an overall depletion of protein synthesis, and leads to the emergence of an adaptive translational program for survival under conditions of cellular stress. Interestingly, NSUN5 epigenetic inactivation also renders these gliomas sensitive to bioactivatable substrates of the stress-related enzyme NQO1. Most importantly, NSUN5 epigenetic inactivation is a hallmark of glioma patients with long-term survival for this otherwise devastating disease
CIBERER : Spanish national network for research on rare diseases: A highly productive collaborative initiative
Altres ajuts: Instituto de Salud Carlos III (ISCIII); Ministerio de Ciencia e Innovación.CIBER (Center for Biomedical Network Research; Centro de Investigación Biomédica En Red) is a public national consortium created in 2006 under the umbrella of the Spanish National Institute of Health Carlos III (ISCIII). This innovative research structure comprises 11 different specific areas dedicated to the main public health priorities in the National Health System. CIBERER, the thematic area of CIBER focused on rare diseases (RDs) currently consists of 75 research groups belonging to universities, research centers, and hospitals of the entire country. CIBERER's mission is to be a center prioritizing and favoring collaboration and cooperation between biomedical and clinical research groups, with special emphasis on the aspects of genetic, molecular, biochemical, and cellular research of RDs. This research is the basis for providing new tools for the diagnosis and therapy of low-prevalence diseases, in line with the International Rare Diseases Research Consortium (IRDiRC) objectives, thus favoring translational research between the scientific environment of the laboratory and the clinical setting of health centers. In this article, we intend to review CIBERER's 15-year journey and summarize the main results obtained in terms of internationalization, scientific production, contributions toward the discovery of new therapies and novel genes associated to diseases, cooperation with patients' associations and many other topics related to RD research
- âŠ